U.S. FDA grants priority review to Roche’s Actemra/RoActemra for the treatment of COVID-19 in…
The FDA has given Priority Review for Actemra/RoActemra (tocilizumab) intravenous for the treatment of COVID-19 in hospitalized adults who are receiving systemic corticosteroids and…
Read More...
Read More...